Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Bill For CBD Supplement Path Draws Mixed Industry Response

Sep 12 2020

• By Eileen Francis

United States Capitol Building at sunset - Washington, DC, USA - Image

Related Content

CBD Format – Spectrum Or Isolate? – Likely To Be Differentiator Tried In FDA Forum, Courts

Mar 26 2020

US FDA Reopens Door For CBD Safety Data, But NPA Says Window Closing For Setting Safe Level

Mar 10 2020

CV Sciences Eagerly Anticipating FDA Rulemaking On CBD In Dietary Supplements

May 01 2020

Congress Ready To Propose Legislation To Deliver US FDA’s Wish: Allowing CBD Use In Supplements

Sep 02 2020

$2m For CBD Policy In FDA Budget, But No Directive On Setting Safe Level

Dec 19 2019

Additional Topics

United States Legislation Cannabidiol CBD FDA Dietary Supplements Regulation Consumer

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window